Ethonafide
Ethonafide (AMP-53) is an anthracene-containing derivative of Amonafide that belongs to the Azonafide series of anticancer agents. Ethonafide (AMP-53) inhibits topoisomerase II activity by stabilizing the enzyme-DNA complex, involving both topoisomerase IIα and β.
For research use only. We do not sell to patients.
- CAS No.: 160554-87-0
- Formula: C22H22N2O3
- Molecular Weight:362.42
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Topoisomerase Isoforms
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
2.9 nM
Compound: 24
|
Tested against A549 lung carcinoma in the sulforhodamine B assay.
Tested against A549 lung carcinoma in the sulforhodamine B assay.
|
[PMID: 8648600] |
| L1210 | IC50 |
6.7 nM
Compound: 24
|
Inhibitory activity against resistant murine leukemia L1210 cell lines.
Inhibitory activity against resistant murine leukemia L1210 cell lines.
|
[PMID: 8648600] |
| L1210 | IC50 |
8 nM
Compound: 24
|
Inhibitory activity against sensitive L1210 cell lines
Inhibitory activity against sensitive L1210 cell lines
|
[PMID: 8648600] |
| L1210 | IC50 |
9.3 nM
Compound: 24
|
An average for IC50 values in the two solid tumor cell lines and sensitive L1210 leukemia cell line.
An average for IC50 values in the two solid tumor cell lines and sensitive L1210 leukemia cell line.
|
[PMID: 8648600] |
| MCF7 | IC50 |
11 nM
Compound: 24
|
Tested against MXF7 breast carcinoma (sensitive) cell line in the sulforhodamine B assay.
Tested against MXF7 breast carcinoma (sensitive) cell line in the sulforhodamine B assay.
|
[PMID: 8648600] |
| MCF7 | IC50 |
14 nM
Compound: 24
|
Tested against MXF7 breast carcinoma (mitoxantrone resistant)cell line in the sulforhodamine B assay.
Tested against MXF7 breast carcinoma (mitoxantrone resistant)cell line in the sulforhodamine B assay.
|
[PMID: 8648600] |
| MCF7 | IC50 |
18 nM
Compound: 24
|
Tested against MXF7 breast carcinoma (doxorubicin resistant) cell line in the sulforhodamine B assay.
Tested against MXF7 breast carcinoma (doxorubicin resistant) cell line in the sulforhodamine B assay.
|
[PMID: 8648600] |
| OVCAR-3 | IC50 |
0.8 nM
Compound: 24
|
Inhibitory activity against OVCAR-3 cell line
Inhibitory activity against OVCAR-3 cell line
|
[PMID: 8648600] |
| UACC-375 | IC50 |
19 nM
Compound: 24
|
Inhibitory activity against AUC375 cell line
Inhibitory activity against AUC375 cell line
|
[PMID: 8648600] |
| WiDr | IC50 |
17 nM
Compound: 24
|
Tested against WiDr colon (sensitive) in the sulforhodamine B assay.
Tested against WiDr colon (sensitive) in the sulforhodamine B assay.
|
[PMID: 8648600] |
| WiDr | IC50 |
63 nM
Compound: 24
|
Tested against WiDr colon carcinoma (resistant) in the sulforhodamine B assay.
Tested against WiDr colon carcinoma (resistant) in the sulforhodamine B assay.
|
[PMID: 8648600] |
Chemical Information
-
CAS No. 160554-87-0
-
Molecular Weight 362.42
-
Formula C22H22N2O3
-
SMILES
O=C1N(CCN(C)C)C(C2=CC=C(OCC)C3=CC4=CC=CC=C4C1=C23)=O
-
Synonyms
AMP-53; 6-Ethoxyazonafide
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Alan Pourpak, et al. Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells. J Pharmacol Exp Ther. 2007 Jun;321(3):1109-17. [Content Brief]
[2]. S M Sami, et al. 6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h] isoquinoline-1,3-diones: synthesis, nucleophilic displacements, antitumor activity, and quantitative structure-activity relationships. J Med Chem. 1996 Apr 12;39(8):1609-18. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)